USPTO serial 79303122
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business project management; Business intelligence services; Business analysis; Business data analysis; Business strategy development and planning; Design and development of marketing, publicity and advertising materials; Development and planning of marketing, publicity and advertising strategies; Business introduction, namely, business networking services; Business representation, namely, public relations agency services; Consultancy, advisory and information services relating to all of the foregoing; Business, marketing, publicity, advertising, business risk management and business development and formation consultancy, advisory and information services | ACTIVE | — |
| 042 | Industrial analysis and industrial research in the fields of medicine, biotechnology and pharmacy and in the field of medical devices, machines, instruments, equipment and apparatus; Industrial design services; Quality control and quality authentication services in the fields of medicine, biotechnology and pharmacy and in the field of medical devices, machines, instruments, equipment and apparatus; Medical and pharmaceutical research; Design and development of medical, pharmaceutical and clinical studies; Design and development of medical experiments, treatments and procedures; Design and development of clinical protocols; Analysis and evaluation of medicines and pharmaceuticals; Analysis and evaluation of medical devices, machines, instruments, equipment and apparatus; Consultancy, advisory and information services relating to all of the foregoing; Design and development of packaging; Medical writing, namely, preparation of regulatory documentation relating to medicines and pharmaceuticals | ACTIVE | — |
| 044 | Pharmacovigilance services, namely, the identification, detection, assessment, analysis, monitoring and prevention of adverse effects in relation to pharmaceuticals; Consultancy, advisory and information services relating to all of the foregoing; Medical and pharmaceutical consultancy, advisory and information services; Consultancy, advisory and information services relating to medicines and pharmaceuticals and to the operation and efficacy of medical devices, machines, instruments, equipment and apparatus | ACTIVE | — |
| 045 | Legal services; Legal services in relation to representation before regulatory authorities; Consultancy, advisory and information services relating to all of the foregoing; Consultancy, advisory and information services relating to legal and regulatory affairs in the fields of medicine and pharmacy and in the field of medical devices, machines, instruments, equipment and apparatus | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 18, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 25, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 25, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 5, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 5, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 21, 2021 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Jul 20, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 20, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 10, 2021 | RINX | USPTO CORRECTION PROCESSED BY IB | — |
| Jul 10, 2021 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jun 30, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 17, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 17, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 17, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 17, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 17, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 15, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 15, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 15, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 9, 2021 | CRSN | CORRECTION SENT TO IB | — |
| Jun 9, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 9, 2021 | CRCR | CORRECTION CREATED FOR IB | — |
| Jun 8, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 8, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 12, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 12, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 6, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 5, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 9, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 3, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 3, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 2, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jan 28, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |